MedAdvisor Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in Australia, New Zealand, the United States, and the United Kingdom. The company provides MedAdvisor, an extension of the pharmacy, that enables the patient to order repeat prescriptions, and schedule vaccinations, etc; and THRiV, an omni-channel intelligent patient management platform, that enables individualized patient engagement through the community pharmacy. MedAdvisor Limited was incorporated in 2010 and is based in Camberwell, Australia.
Stock data | 2023 | Change |
---|---|---|
Price | $0.3085281196552534 | N/A |
Market Cap | $168.74M | N/A |
Shares Outstanding | 546.93M | 44.64% |
Employees | 0 | N/A |
Shareholder Equity | 48.46M | 40.28% |
Valuation | 2023 | Change |
---|---|---|
P/S Ratio | 2.57 | N/A |
P/B Ratio | 3.48 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | -0.1565 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $65.71M | N/A |
Earnings | -$7.58M | N/A |
Gross Margin | 0.6064 | N/A |
Operating Margin | -0.0861 | N/A |
Net income margin | -0.1154 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $64.33M | N/A |
Total Debt | $8.78M | N/A |
Cash on Hand | $9.52M | N/A |
Debt to Equity | 0.6567 | -22.95% |
Cash to Debt | $1.08 | 91.95% |
Current Ratio | 0.8473 | 61.71% |